Thoracic Oncology: Current Challenges and Future Prospects
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 25 August 2026 | Viewed by 28
Special Issue Editors
2. Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy
Interests: lung cancer; thoracic surgery; thoracic oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thoracic oncology has witnessed remarkable changes as a result of advances in molecular biology, imaging technologies, personalized medicine, and minimally invasive surgery.
Thoracic malignancies, including lung cancer, mesothelioma, and mediastinal tumors, remain a substantial global health burden characterized by high incidence, late-stage diagnosis, and differential response to therapy, despite significant advances. While we are in a unique, unprecedented period of new therapies and treatment approach development, there are still multiple clinical and scientific barriers to overcome before we can achieve the genuine success of our treatment methods, including early detection, treatment resistance, best patient selection, and long-term results.
This Special Issue, titled Thoracic Oncology: Current Challenges and Future Prospects, will provide an updated overview of the current state of the art in thoracic oncology, as well as outline unmet needs and potential pathways for future research. Novel subjects include screening and early detection, biomarkers, immunotherapy and targeted therapies, perioperative treatment, "thoracic" surgery, oligometastatic disease, and multimodality therapy. Special emphasis will be dedicated to translational research, such as liquid biopsy, radiogenomics, tumor microenvironment profiling, and artificial intelligence for prediction, classification, and decision making.
The best submissions addressing mechanisms of resistance, minimal residual disease, quality-of-life and patient-reported outcomes should be at the cutting edge of research. We are also interested in novel surgical technologies that include, but are not limited to, robotic and image-guided surgical procedures.
We invite original research articles, clinical studies, systematic reviews and meta-analyses, translational studies, and high-quality narrative reviews. We also encourage multidisciplinary contributions spanning thoracic surgery, oncology, radiology, pathology, molecular science, and computational medicine.
Dr. Luca Bertolaccini
Guest Editor
Dr. Claudia Bardoni
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thoracic oncology
- lung cancer
- mesothelioma
- mediastinal tumors
- immunotherapy
- artificial intelligence
- targeted therapy
- screening
- early detection
- biomarkers
- liquid biopsy
- radiomics
- radiogenomics
- robotic surgery
- multimodality treatment
- oligometastatic disease
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
